1[期刊论文]

CNS repurposing - Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity

作者：Chris G. Parsons

来源：Neuropharmacology. 2019 ;147:4-10.doi:10.1016/j.neuropharm.2018.08.027

出版社：Elsevier BV

全文购买

2[期刊论文]

NMDA receptors as targets for drug action in neuropathic pain

作者：Chris G Parsons

来源：European Journal of Pharmacology. 2001 ;429(1-3):71-78.doi:10.1016/S0014-2999(01)01307-3

出版社：Elsevier BV

全文购买

3[期刊论文]

Neuroprotective potential of ionotropic glutamate receptor antagonists

作者：Wojciech Danysz ;Chris G. Parsons

来源：Neurotoxicity Research. 2002 ;4(2):119-126.doi:10.1080/10298420290015872

出版社：Springer Nature

全文购买

4[期刊论文]

Chronic memantine does not block 3-nitropropionic acid-delayed ischaemic tolerance in rat hippocampal slicesex vivo

作者：Tadeusz Frankiewicz ;Chris G. Parsons

来源：Neurotoxicity Research. 2003 ;5(8):617-622.doi:10.1007/BF03033181

出版社：Springer Nature

全文购买

5[期刊论文]

Preclinical to phase II amyloid beta (Aβ) peptide modulators under investigation for Alzheimer’s disease

作者：Chris G. Parsons ;Gerhard Rammes

来源：Expert Opinion on Investigational Drugs. 2017 ;26(5):579-592.doi:10.1080/13543784.2017.1313832

出版社：Informa Healthcare

全文购买

6[期刊论文]

Memantine restores long term potentiation impaired by tonic N-methyl-d-aspartate (NMDA) receptor activation following reduction of Mg2+ In hippocampal slices

作者：Tadeusz Frankiewicz ;Chris G Parsons

来源：Neuropharmacology. 1999 ;38(9):1253-1259.doi:10.1016/S0028-3908(99)00060-X

出版社：Elsevier BV

全文购买

7[期刊论文]

The Aβ aggregation modulator MRZ-99030 prevents and even reverses synaptotoxic effects of Aβ1-42 on LTP even following serial dilution to a 500:1 stoichiometric excess of Aβ1-42, suggesting a beneficial prion-like seeding mechanism

作者：Gerhard Rammes ;Chris G. Parsons

来源：Neuropharmacology. 2020 ;179:108267.doi:10.1016/j.neuropharm.2020.108267

出版社：Elsevier BV

全文购买

8[期刊论文]

Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine – searching for the connections

作者：Wojciech Danysz ;Chris G Parsons

来源：British Journal of Pharmacology. 2012 ;167(2):324-352.doi:10.1111/j.1476-5381.2012.02057.x

出版社：John Wiley & Sons, Ltd.

开放获取

9[期刊论文]

The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer‘s disease: preclinical evidence

作者：Wojciech Danysz ;Chris G. Parsons

来源：International Journal of Geriatric Psychiatry. 2003 ;18(S1):S23-S32.doi:10.1002/gps.938

出版社：John Wiley & Sons, Ltd.

全文购买

10[期刊论文]

Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse

作者：Chris G. Parsons ;Albrecht Stöffler ;Wojciech Danysz

来源：Neuropharmacology. 2007 ;53(6):699-723.doi:10.1016/j.neuropharm.2007.07.013

出版社：Elsevier BV

全文购买